Viewing Study NCT02397720

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2026-02-24 @ 3:52 PM
Study NCT ID: NCT02397720
Status: COMPLETED
Last Update Posted: 2025-06-08
First Post: 2015-03-19
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Bilineal Leukemia View
None Acute Biphenotypic Leukemia View
None Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome View
None Chronic Myelomonocytic Leukemia View
None Myelodysplastic Syndrome View
None Recurrent Acute Myeloid Leukemia View
None Refractory Acute Myeloid Leukemia View
None Secondary Acute Myeloid Leukemia View
None Therapy-Related Acute Myeloid Leukemia View
Keywords: